4.8 Article

AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0507313103

关键词

amyloid precursor protein; glutamate; presenilin

资金

  1. NEI NIH HHS [R01 EY008055-09, P30 EY013079-069003, P30 EY013079, R01 EY013145-04, R01 EY013145] Funding Source: Medline
  2. NINDS NIH HHS [R25 NS080686, R01 NS041091, R01 NS041091-04] Funding Source: Medline

向作者/读者索取更多资源

It is widely thought that Alzheimer's disease (AD) begins as a malfunction of synapses, eventually leading to cognitive impairment and dementia. Homeostatic synaptic scaling is a mechanism that could be crucial at the onset of AD but has not been examined experimentally. In this process, the synaptic strength of a neuron is modified so that the overall excitability of the cell is maintained. Here, we investigate whether synaptic scaling mediated by L-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) contributes to pathology in double knockin (2 x KI) mice carrying human mutations in the genes for amyloid precursor protein and presenilin-1. By using whole-cell recordings, we show that 2 x KI mice exhibit age-related downscaling of AMPAR-mediated evoked currents and spontaneous, miniature currents. Electron microscopic analysis further corroborates the synaptic AMPAR decrease. Additionally, 2 x KI mice show age-related deficits in bidirectional plasticity (long-term potentiation and long-term depression) and memory flexibility. These results suggest that AMPARs are important synaptic targets for AD and provide evidence that cognitive impairment may involve downscaling of postsynaptic AMPAR function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据